Intervention to reduce the risk of diabetic retinopathy and early adverse retinal changes in type 1 diabetes

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

The long term effects of young onset T1D may be devastating: diabetes is the leading cause of visual loss in young adults in Australia and other countries. We have the unique opportunity to investigate whether ACEI and statins will modify retinopathy through our collaboration with an already funded international multicentre trial. This study will treat adolescents for 4 years and will follow them for the next 5-10 years. We will use novel measures of retinal blood vessels size and fractals.

Funded Activity Details

Start Date: 01-01-2010

End Date: 01-01-2015

Funding Scheme: Project Grants

Funding Amount: $1,294,846.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Endocrinology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

ACE inhibitors | Adolescents with type 1 diabetes | Blood pressure and lipid lowering intervention | Diabetic retinopathy in type 1 diabetes | Retinal protection | Statins | atherosclerosis | childhood diabetes | statins